Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

1.

The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study.

Mackenzie T, Leary L, Brooks WB.

Metabolism. 2007 Oct;56(10):1340-4.

PMID:
17884442
[PubMed - indexed for MEDLINE]
2.

Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities.

Fukino Y, Ikeda A, Maruyama K, Aoki N, Okubo T, Iso H.

Eur J Clin Nutr. 2008 Aug;62(8):953-60. Epub 2007 Jun 6.

PMID:
17554248
[PubMed - indexed for MEDLINE]
3.

Safety profile and metabolic effects of 14 days of treatment with DIO-902: results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitus.

Schwartz SL, Rendell M, Ahmann AJ, Thomas A, Arauz-Pacheco CJ, Welles BR.

Clin Ther. 2008 Jun;30(6):1081-8. doi: 10.1016/j.clinthera.2008.05.021.

PMID:
18640464
[PubMed - indexed for MEDLINE]
4.

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. doi: 10.1016/j.clinthera.2008.08.006. Erratum in: Clin Ther. 2008 Oct;30(10):1937.

PMID:
18803987
[PubMed - indexed for MEDLINE]
5.

Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.

Schwartz SL, Ratner RE, Kim DD, Qu Y, Fechner LL, Lenox SM, Holcombe JH.

Clin Ther. 2008 May;30(5):858-67. doi: 10.1016/j.clinthera.2008.05.004.

PMID:
18555933
[PubMed - indexed for MEDLINE]
7.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
[PubMed - indexed for MEDLINE]
8.

Green tea attenuates diabetes induced Maillard-type fluorescence and collagen cross-linking in the heart of streptozotocin diabetic rats.

Babu PV, Sabitha KE, Srinivasan P, Shyamaladevi CS.

Pharmacol Res. 2007 May;55(5):433-40. Epub 2007 Feb 2.

PMID:
17336542
[PubMed - indexed for MEDLINE]
9.

Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes.

Covington P, Christopher R, Davenport M, Fleck P, Mekki QA, Wann ER, Karim A.

Clin Ther. 2008 Mar;30(3):499-512. doi: 10.1016/j.clinthera.2008.03.004.

PMID:
18405788
[PubMed - indexed for MEDLINE]
10.

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy.

Pratley RE, Kipnes MS, Fleck PR, Wilson C, Mekki Q; Alogliptin Study 007 Group.

Diabetes Obes Metab. 2009 Feb;11(2):167-76. doi: 10.1111/j.1463-1326.2008.01016.x.

PMID:
19125778
[PubMed - indexed for MEDLINE]
11.
12.
13.
14.

Effects of sour tea (Hibiscus sabdariffa) on lipid profile and lipoproteins in patients with type II diabetes.

Mozaffari-Khosravi H, Jalali-Khanabadi BA, Afkhami-Ardekani M, Fatehi F.

J Altern Complement Med. 2009 Aug;15(8):899-903. doi: 10.1089/acm.2008.0540.

PMID:
19678781
[PubMed - indexed for MEDLINE]
Free Article
15.

Glucose-lowering effect of powder formulation of African black tea extract in KK-A(y)/TaJcl diabetic mouse.

Shoji Y, Nakashima H.

Arch Pharm Res. 2006 Sep;29(9):786-94.

PMID:
17024853
[PubMed - indexed for MEDLINE]
16.

Xiaoke tea, a Chinese herbal treatment for diabetes mellitus.

Hale PJ, Horrocks PM, Wright AD, Fitzgerald MG, Nattrass M, Bailey CJ.

Diabet Med. 1989 Nov;6(8):675-6.

PMID:
2532099
[PubMed - indexed for MEDLINE]
17.

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.

Goldberg RB, Fonseca VA, Truitt KE, Jones MR.

Arch Intern Med. 2008 Jul 28;168(14):1531-40. doi: 10.1001/archinte.168.14.1531.

PMID:
18663165
[PubMed - indexed for MEDLINE]
18.

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.

PMID:
18936501
[PubMed - indexed for MEDLINE]
20.

Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias.

Batista Gde A, Cunha CL, Scartezini M, von der Heyde R, Bitencourt MG, Melo SF.

Arq Bras Cardiol. 2009 Aug;93(2):128-34.

PMID:
19838489
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk